Clinical Trial: A Clinical Study of AK0610

U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996704) titled 'A Clinical Study of AK0610' on March 24.

Brief Summary: The study consists of two parts: dose escalation and expansion. It includes five cohorts in the dose-escalation phase and two expansion cohorts based on pharmacokinetic data.

Study Start Date: Feb. 29, 2024

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer Study

Intervention: DRUG: AK0610 Injection solution

Active Substance: AK0610 Pharmaceutical Form: Injection solution Route of Administration: Intramuscular injection or intravenous injection.

DRUG: Placebo

Active Substance: Placebo Pharmaceutical Form: Injection Route of Administration: Intramuscular injection o...